Skip to main content
UniHealth

Doctor search

Jennie R Crews, MD

Medical Oncology · Stanford

NPI 1609987874

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1
Since medical school
36 years
Duke University School of Medicine, 1990

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Crews’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence C182678 · Current

Licensed to practise in California · since 2022 · expires 2028-10-31 · Duke University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Washington MD.MD.60265937Physician And Surgeon License · since 2012 · expires 2026-11-28
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Medical Oncology

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$5,560

Medicare paid this office $5,560 for 30 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)20$3,161$126
Return visit (30+ min)11$738$67

Who their Medicare patients are

30 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 0.86. At or below the middle of the specialty; the typical medical oncology clinician is at 2.11.

Conditions among them: Cancer 75% · High blood pressure 53%.

The office billed $12,056, Medicare allowed $7,842 and paid $5,560; for 49 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243049750.86$12,056$5,560
20232532720.76$7,353$3,992
20211616711.50$5,895$1,752
20202627681.30$10,260$2,463
20191717692.08$4,819$1,899
2016248723731.68$130,743$47,145
2015207617731.59$141,281$46,892
2014132403731.66$97,210$28,630
2013106382751.48$70,534$24,348

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Long return visit (40+ min)16$2,111$117

2020: 1 service

Original Medicare services billed in 2020
Long return visit (40+ min)11$982$89

2016: 11 services

Original Medicare services billed in 2016
Return visit (30+ min)101$10,476$55
Return visit (30+ min)59$10,377$86
Long return visit (40+ min)33$5,414$81
Short return visit (20+ min)75$3,277$35
New patient visit (45+ min)20$2,636$132
Short return visit (20+ min)33$2,468$56
Long return visit (40+ min)12$2,059$108
New patient visit (60+ min)12$2,008$167
New patient visit (60+ min)15$1,815$121
New patient visit (45+ min)17$1,609$95
Telehealth originating site facility fee49$1,496$19

2015: 10 services

Original Medicare services billed in 2015
Return visit (30+ min)99$10,742$57
Long return visit (40+ min)42$10,096$81
Return visit (30+ min)42$6,014$85
Long return visit (40+ min)14$3,562$111
New patient visit (60+ min)26$3,237$124
New patient visit (60+ min)13$2,380$183
Short return visit (20+ min)32$2,376$63
Short return visit (20+ min)46$2,122$35
New patient visit (45+ min)12$1,846$154
New patient visit (45+ min)12$1,092$91

2014: 5 services

Original Medicare services billed in 2014
Return visit (30+ min)63$8,586$60
Long return visit (40+ min)33$5,392$86
New patient visit (60+ min)27$3,551$132
Return visit (30+ min)20$3,495$78
Short return visit (20+ min)41$2,398$37

2013: 4 services

Original Medicare services billed in 2013
Return visit (30+ min)50$10,043$57
Short return visit (20+ min)54$3,454$37
New patient visit (60+ min)28$3,385$121
Short return visit (20+ min)11$998$55

Drugs they prescribed that Part D paid

$1,131

Pharmacies billed $1,131 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 44) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

44 generic and 0 brand-name prescriptions · $1,131 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tamoxifen Citrate16$372$23
Anastrozole15$154$10

Year by year

Part D prescribing by year
202444130% (0)0%$1,131
201714358None10%$116,522
20161,00017311% (114)15%$640,326
201585713411% (93)14%$418,757
201463411012% (78)None$363,177
20134019315% (59)9%$136,194

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2017: 2 drugs

Part D drugs prescribed in 2017
Anastrozole37$661$18
Letrozole39$513$13

2016: 24 drugs

Part D drugs prescribed in 2016
Revlimid17$208,608$12,271
Exemestane17$3,959$233
Letrozole131$2,804$21
Lorazepam54$2,700$50
Ursodiol12$1,815$151
Morphine Sulfate Er22$1,515$69
Anastrozole51$878$17
Hydrocodone-Acetaminophen34$862$25
Tamoxifen Citrate14$695$50
Ondansetron28$566$20
Gabapentin26$539$21
Oxycodone19$406$21
Omeprazole39$300$8
Dexamethasone38$257$7
Prochlorperazine Maleate39$234$6
Prednisone24$178$7
Warfarin18$149$8
Sertraline15$116$8
Levothyroxine12$114$10
Mirtazapine15$103$7
Alendronate11$54$5
Trazodone12$50$4
Hydrochlorothiazide12$26$2
Furosemide12$17$1

2015: 25 drugs

Part D drugs prescribed in 2015
Revlimid13$138,106$10,624
Exemestane21$7,182$342
Letrozole140$2,802$20
Morphine Sulfate Er19$2,204$116
Lorazepam48$2,118$44
Hydrocodone-Acetaminophen20$723$36
Oxycodone22$671$31
Ondansetron27$538$20
Anastrozole19$443$23
Zolpidem15$335$22
Tamoxifen Citrate15$283$19
Hydroxyurea13$237$18
Gabapentin20$166$8
Venlafaxine14$156$11
Prednisone22$155$7
Dexamethasone13$132$10
Prochlorperazine Maleate30$131$4
Omeprazole30$129$4
Warfarin19$117$6
Mirtazapine17$93$5
Alprazolam14$63$5
Trazodone14$54$4
Lisinopril16$54$3
Hydrochlorothiazide12$28$2
Furosemide13$15$1

2014: 13 drugs

Part D drugs prescribed in 2014
Morphine Sulfate Er24$4,594$191
Actonel14$2,772$198
Lorazepam42$2,339$56
Letrozole106$2,198$21
Ondansetron31$539$17
Ondansetron Odt15$375$25
Warfarin35$328$9
Hydrocodone-Acetaminophen14$289$21
Oxycodone12$246$20
Dexamethasone14$147$10
Prednisone15$120$8
Prochlorperazine Maleate21$94$4
Mirtazapine13$49$4

2013: 8 drugs

Part D drugs prescribed in 2013
Letrozole80$2,346$29
Lorazepam31$710$23
Bicalutamide18$633$35
Bupropion Hcl Sr11$444$40
Ondansetron24$387$16
Anastrozole21$332$16
Prochlorperazine Maleate16$130$8
Prednisone11$99$9

Money from drug and device companies

$1,181 in 2021

Industry payments by year
202123$1,181$1,181
202012$1,500$1,500

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.None$1,109
2 payments
  • Paid to speak or teach · 2021-12-31 · $1,000
  • Paid to speak or teach · 2021-06-22 · $109
AstraZeneca Pharmaceuticals LPNone$72
1 payment
  • Paid to speak or teach · 2021-06-22 · $72
See all 3 published payments
Every published payment
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2021-12-31None$1,000
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2021-06-22None$72
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2021-06-22None$109
See earlier years (2020)

2020: $1,500

Payments by company in 2020
E.R. Squibb & Sons L.L.C.None$1,500
2 payments
  • Paid to speak or teach · 2020-03-23 · $500
  • Paid to speak or teach · 2020-01-21 · $1,000

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Amgen Inc. · Prospective Observational Study of Onpro Vs Soc. · 2020Their institution$17,145
Amgen Inc. · Prospective Observational Study of Onpro Vs Soc. · 2021Their institution$5,715

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1609987874
Licence
CA C182678, WA MD60265937California C182678: Current · expires 2028-10-31Washington MD.MD.60265937: Active
Trained
Duke University School of Medicine, 1990 · 36 years ago
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
NC 3400038, WA 1609987874
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X); Federal specialty code 207RH0003X (207RH0003X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2006-08-31
NPI last updated
2024-04-28
NPI record certified
2024-04-28

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 825 Eastlake Ave E, Seattle, WA, 98109